Evidence‑based advocacy that restores essential diabetes technology.
This case shows how a denied request for the Dexcom G7 continuous glucose monitor was successfully overturned through clear clinical documentation and strong policy alignment. The appeal demonstrated the patient’s medical need for continuous glucose monitoring, addressed the insurer’s denial rationale, and connected the clinical evidence directly to coverage criteria. By presenting a structured, evidence‑supported argument grounded in safety, treatment history, and risk factors, the appeal established medical necessity and secured full approval for the Dexcom G7.

